Cargando…

Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world

Detalles Bibliográficos
Autores principales:	Kaku, Sawako, Horinouchi, Hidehito, Watanabe, Hirokazu, Yonemori, Kan, Okusaka, Takuji, Boku, Narikazu, Yamazaki, Naoya, Kawai, Akira, Ohe, Yuichiro, Kusumoto, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189089/ https://www.ncbi.nlm.nih.gov/pubmed/35652958 http://dx.doi.org/10.1007/s00432-022-04077-z

Ejemplares similares

Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world
por: Kaku, Sawako, et al.
Publicado: (2022)

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease
por: Udagawa, Chihiro, et al.
Publicado: (2019)

Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice
por: Ida, Hanae, et al.
Publicado: (2022)

Current treatment strategies for EGFR-mutated non-small cell lung cancer: from first line to beyond osimertinib resistance
por: Araki, Taisuke, et al.
Publicado: (2023)

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
por: Okusaka, Takuji, et al.
Publicado: (2015)

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer
por: Okusaka, Takuji, et al.
Publicado: (2014)

Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990)

Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979)

“Real” Tumor-Spread Through Air Spaces of Lung Adenocarcinoma Presented Intrapulmonary Metastases Through Bronchiole Air Spaces: A Case Report
por: Kaku, Sawako, et al.
Publicado: (2022)

Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020)

Drug induced interstitial lung disease in oncology phase I trials
por: Yonemori, Kan, et al.
Publicado: (2016)

Electrolyte Disorders Induced by Antineoplastic Drugs
por: Verzicco, Ignazio, et al.
Publicado: (2020)

Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
por: Layton, Jodi L., et al.
Publicado: (2018)

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer
por: Oshima, Kotoe, et al.
Publicado: (2022)

Tumor targeting using liposomal antineoplastic drugs
por: Huwyler, Jörg, et al.
Publicado: (2008)

Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
por: Ralph, Stephen John
Publicado: (2008)

Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells
por: Eschenburg, Georg, et al.
Publicado: (2014)

Nivolumab‐induced radiation recall pneumonitis in non‐small‐cell lung cancer patients with thoracic radiation therapy
por: Noda‐Narita, Shoko, et al.
Publicado: (2022)

Efficacy and safety of axitinib in combination with gemcitabine in advanced pancreatic cancer: subgroup analyses by region, including Japan, from the global randomized Phase III trial
por: Ioka, Tatsuya, et al.
Publicado: (2015)

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
por: Suzuki, Eiichiro, et al.
Publicado: (2013)

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study
por: Kitadai, Rui, et al.
Publicado: (2021)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)

Mesenchymal Stromal Cells for Antineoplastic Drug Loading and Delivery
por: Petrella, Francesco, et al.
Publicado: (2017)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

Ototoxic effects of antineoplastic drugs: a systematic review
por: Patatt, Fernanda Soares Aurélio, et al.
Publicado: (2021)

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview
por: Roger, Inés, et al.
Publicado: (2023)

Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
por: Tsubokura, Misato, et al.
Publicado: (2022)

Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignancies
por: Tanaka, Midori, et al.
Publicado: (2018)

Usefulness of Simple Original Interstitial Lung Abnormality Scores for Predicting Radiation Pneumonitis Requiring Steroidal Treatment After Definitive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Kashihara, Tairo, et al.
Publicado: (2020)

Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer
por: Takamizawa, Shigemasa, et al.
Publicado: (2021)

Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease
por: Li, Xiao, et al.
Publicado: (2023)

Monitoring of Oxidative Stress in Nurses Occupationally Exposed to Antineoplastic Drugs
por: Mahboob, M., et al.
Publicado: (2012)

The reversal of antineoplastic drug resistance in cancer cells by β-elemene
por: Zhang, Guan-Nan, et al.
Publicado: (2015)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach
por: Rattner, Jodi, et al.
Publicado: (2017)

Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2019)

Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic Drugs
por: Papanagnou, Panagiota, et al.
Publicado: (2016)

The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs
por: Cui, Hui, et al.
Publicado: (2020)

Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs
por: Todorov, Lozan, et al.
Publicado: (2023)

Cell death regulation in myocardial toxicity induced by antineoplastic drugs
por: Yu, Xue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g1012alg7k85ab89gtd44fmfnn